The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...
Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...
1d
We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...
The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...
The pharmaceutical packaging equipment market is growing rapidly, driven by increasing demand for automation, regulatory compliance, and the rise of biologics and personalized medicines. Advanced ...
The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback